138 related articles for article (PubMed ID: 8588133)
1. Transmission of hepatitis C virus by transfusion in Orebro County, Sweden, 1990-1992.
Norda R; Duberg AS; Sönnerborg A; Olcén P
Scand J Infect Dis; 1995; 27(5):449-52. PubMed ID: 8588133
[TBL] [Abstract][Full Text] [Related]
2. Outcome of an optional HCV screening program for blood transfusion recipients in Ireland.
Davoren A; Dillon AD; Power JP; Donnellan J; Quinn JM; Willis JW; Lawlor EM; O'Riordan JM
Transfusion; 2002 Nov; 42(11):1501-6. PubMed ID: 12421225
[TBL] [Abstract][Full Text] [Related]
3. Transmission of viral hepatitis through blood transfusion in Sweden, 1968 to 2012.
Dahl V; Majeed A; Wikman A; Norda R; Edgren G
Euro Surveill; 2020 Jul; 25(29):. PubMed ID: 32720634
[TBL] [Abstract][Full Text] [Related]
4. Transmission of HCV infection by RIBA indeterminate and positive blood units.
Kolho E; Naukkarinen R; Krusius T
Transfus Med; 1992 Sep; 2(3):243-8. PubMed ID: 1285012
[TBL] [Abstract][Full Text] [Related]
5. Risk of hepatitis C infection in neonates transfused with blood from donors infected with hepatitis C.
O'Riordan JM; Conroy A; Nourse C; Yap PL; McDonald GS; Kaminski G; Leong K; Lawlor E; Davoren A; Strong K; Davidson F; Lloyd A; Power J
Transfus Med; 1998 Dec; 8(4):303-8. PubMed ID: 9881424
[TBL] [Abstract][Full Text] [Related]
6. Prospective study of the meaning of indeterminate results of the recombinant immunoblot assay for hepatitis C virus in blood donors.
Piro L; Solinas S; Luciani M; Casale A; Bighiani T; Santonocito D; Girelli G
Blood Transfus; 2008 Apr; 6(2):107-11. PubMed ID: 18946955
[TBL] [Abstract][Full Text] [Related]
7. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.
Conry-Cantilena C; VanRaden M; Gibble J; Melpolder J; Shakil AO; Viladomiu L; Cheung L; DiBisceglie A; Hoofnagle J; Shih JW
N Engl J Med; 1996 Jun; 334(26):1691-6. PubMed ID: 8637513
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology, serological markers, and hepatic disease of anti-HCV ELISA-2-positive blood donors.
Salmerón FJ; Palacios A; Pérez-Ruiz M; Torres C; Oyonarte S; Fernández-Montoya A; Ruiz-Extremera A
Dig Dis Sci; 1996 Oct; 41(10):1933-8. PubMed ID: 8888703
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus (HCV) RNA among anti-HCV-positive blood donors and their recipients.
Skaug K; Li H; Jonassen TO; Larsen J; Figenschau KJ
Vox Sang; 1993; 64(4):215-9. PubMed ID: 7685969
[TBL] [Abstract][Full Text] [Related]
10. Outcome of post-transfusion hepatitis C: disease severity in blood-component recipients and their implicated donors.
Smith BC; Chapman CE; Burt AD; Toms GL; Bassendine MF
QJM; 1997 Sep; 90(9):587-92. PubMed ID: 9349451
[TBL] [Abstract][Full Text] [Related]
11. Detection of hepatitis C virus infection among cadaver organ donors: evidence for low transmission of disease.
Roth D; Fernandez JA; Babischkin S; De Mattos A; Buck BE; Quan S; Olson L; Burke GW; Nery JR; Esquenazi V
Ann Intern Med; 1992 Sep; 117(6):470-5. PubMed ID: 1323944
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus transmission, 1988-1991, via blood components from donors subsequently found to be anti-HCV-positive.
Foberg U; Ekermo B; Widell A; Mathiesen U; Fryden A
Scand J Infect Dis; 1996; 28(1):21-6. PubMed ID: 9122627
[TBL] [Abstract][Full Text] [Related]
13. Transfusion transmission of HCV infection before anti-HCV testing of blood donations in England: results of the national HCV lookback program.
Transfusion; 2002 Sep; 42(9):1146-53. PubMed ID: 12430671
[TBL] [Abstract][Full Text] [Related]
14. Also with a restrictive transfusion policy, screening with second-generation anti-hepatitis C virus enzyme-linked immunosorbent assay would have reduced post-transfusion hepatitis C after open-heart surgery.
Mathiesen UL; Karlsson E; Foberg U; Frydén A; Franzén L; Widell A; Bodemar G
Scand J Gastroenterol; 1993 Jul; 28(7):581-4. PubMed ID: 7689744
[TBL] [Abstract][Full Text] [Related]
15. Indeterminate RIBA results were associated with the absence of hepatitis C virus RNA (HCV-RNA) in blood donors.
Pereira FM; Zarife MA; Reis EA; G Reis M
Rev Soc Bras Med Trop; 2014; 47(1):12-7. PubMed ID: 24603731
[TBL] [Abstract][Full Text] [Related]
16. Prevalence & significance of hepatitis C virus (HCV) seropositivity in blood donors.
Thakral B; Marwaha N; Chawla YK; Saluja K; Sharma A; Sharma RR; Minz RW; Agnihotri SK
Indian J Med Res; 2006 Oct; 124(4):431-8. PubMed ID: 17159264
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus (HCV) infection in bone marrow transplant patients after transfusions from anti-HCV-positive blood donors.
Shuhart MC; Myerson D; Spurgeon CL; Bevan CA; Sayers MH; McDonald GB
Bone Marrow Transplant; 1996 Apr; 17(4):601-6. PubMed ID: 8722362
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of antibodies to hepatitis C virus in populations at low and high risk for sexually transmitted diseases in Rio de Janeiro.
Edelenyi-Pinto M; Carvalho AP; Nogueira C; Ferreira Júnior O; Schechter M
Mem Inst Oswaldo Cruz; 1993; 88(2):305-7. PubMed ID: 7509022
[TBL] [Abstract][Full Text] [Related]
19. Donor-to-donor and donor-to-patient transmission of hepatitis C virus.
Kitchen AD; Wallis PA; Gorman AM
Vox Sang; 1996; 70(2):112-3. PubMed ID: 8801758
[TBL] [Abstract][Full Text] [Related]
20. Risk factor exposure among hepatitis C virus RNA positive Swedish blood donors--the role of parenteral and sexual transmission.
Shev S; Hermodsson S; Lindholm A; Malm E; Widell A; Norkrans G
Scand J Infect Dis; 1995; 27(2):99-104. PubMed ID: 7544914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
